(Q33520508)

English

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

0 references

bowel dysfunction

1 reference

based on heuristic

inferred from title

object named as

Gerd Mikus

2

0 references

Katri Elina Clemens

1

object named as

Katri Elina Clemens

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

297-310

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Fluorescence in situ hybridization and chromosome studies after transfusion in newborns: is a waiting period necessary?

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Incidence, prevalence, and management of opioid bowel dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioids and their complicated receptor complexes

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Randomised trial of oral morphine for chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Gastrointestinal side effects in chronic opioid users: results from a population-based survey

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioid antagonists in the treatment of opioid-induced constipation and pruritus

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Methylnaltrexone for opioid-induced constipation in advanced illness

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Antinociceptive effect of oxycodone in diabetic mice

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Characterization and validation of a pharmacokinetic model for controlled-release oxycodone

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Low-dose oral naloxone reverses opioid-induced constipation and analgesia

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Oral naloxone reverses opioid-associated constipation

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioids and the gut: pharmacology and current clinical experience.

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

The safety and value of naloxone as a therapeutic aid.

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Naloxone treatment in opioid addiction: the risks and benefits

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Treatment of opioid-induced constipation with oral naloxone: A pilot study

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Opioid-induced bowel dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Two New Rating Scales for Opiate Withdrawal

1 reference

https://api.crossref.org/works/10.1517%2F14656560903483222

21 January 2018

Identifiers

10.1517/14656560903483222

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33520508&oldid=2057291836"